scholarly journals Watermelon stomach in a patient with primary Sjögren's syndrome

2010 ◽  
Vol 67 (3) ◽  
pp. 256-258 ◽  
Author(s):  
Miodrag Krstic ◽  
Tamara Alempijevic ◽  
Sladjana Andrejevic ◽  
Maja Zlatanovic ◽  
Nemanja Damjanov ◽  
...  
Keyword(s):  
Gastrointestinal Bleeding ◽  
Argon Plasma Coagulation ◽  
Argon Plasma ◽  
Autoimmune Disorder ◽  
Autoimmune Disorders ◽  
Deficiency Anemia ◽  
Gastric Antral Vascular Ectasia ◽  
Watermelon Stomach ◽  
Vascular Ectasia ◽  
Rare Case Report

Introduction. Watermelon stomach (WS) or gastric antral vascular ectasia (GAVE) is a rare cause of upper gastrointestinal bleeding described in a variety of autoimmune disorders. Association of watermelon stomach with Sj?gren's syndrome is extremely rare. Case report. We presented a 67-year old female with primary Sj?gren's syndrome (SS) who had developed a persistent severe iron-deficiency anemia. An upper gastric endoscopy revealed the presence of gastric antral vascular ectasia (GAVE) as a cause of occult gastrointestinal bleeding. The treatment with argon-plasma coagulation was postponed as the conservative therapy with iron substitution and proton pump inhibitor led to improvement of anemia and hemoglobin levels normalization. Conclusion. This is the first report of WS in a patient with primary SS without the presence of coexisting autoimmune disorder. Recognition of this rare, but clinically important, cause of gastrointestinal bleeding may decrease comorbidity in patients with autoimmune disorders including primary Sj?gren's syndrome.

Endoscopic mucosal resection for recurrent gastric antral vascular ectasia

VASA ◽  
2008 ◽  
Vol 37 (3) ◽  
pp. 289-292 ◽  
Author(s):  
Katsinelos ◽  
Chatzimavroudis ◽  
Katsinelos ◽  
Panagiotopoulou ◽  
Kotakidou ◽  
...  
Keyword(s):  
Endoscopic Mucosal Resection ◽  
Argon Plasma Coagulation ◽  
Argon Plasma ◽  
Deficiency Anemia ◽  
Gastric Antral Vascular Ectasia ◽  
Therapeutic Approaches ◽  
Plasma Coagulation ◽  
Vascular Ectasia ◽  
Mucosal Resection ◽  
First Case

Gastric antral vascular ectasia (GAVE) is an overt or occult source of gastrointestinal bleeding. Despite several therapeutic approaches have been successfully tested for preventing chronic bleeding, some patients present recurrence of GAVE lesions. To the best of our knowledge, we report the first case, of a 86-year-old woman who presented severe iron-deficiency anemia due to GAVE and showed recurrence of GAVE lesion despite the intensive argon plasma coagulation treatment. We performed endoscopic mucosal resection of bleeding GAVE with resolution of anemia.

Successful treatment of refractory Gastric Antral Vascular Ectasia (GAVE) in a cirrhotic patient with transcatheter arterial embolisation in a tertiary care facility in Pakistan: a case report

2021 ◽  
pp. 1-7
Author(s):  
Laima Alam ◽  
Ayesha Usmani ◽  
Admin
Keyword(s):  
Gastrointestinal Bleeding ◽  
Argon Plasma Coagulation ◽  
Tertiary Care ◽  
Argon Plasma ◽  
Care Facility ◽  
Gastric Antral Vascular Ectasia ◽  
Plasma Coagulation ◽  
Vascular Ectasia ◽  
Tertiary Care Facility ◽  
Arterial Embolisation

Abstract Gastric antral vascular ectasia (GAVE) is a rare but important cause of upper gastrointestinal bleeding that may present with refractory anaemia or overt gastrointestinal bleeding requiring multiple admissions and resuscitation. Although endoscopic therapies are considered first line treatment for the management of refractory gastric antral vascular ectasia, angiographic embolisation of the culprit vessel(s) may emerge as an effective and safe treatment modality in the near future. Here, we present the case of a middle-aged gentleman with refractory gastric antral vascular ectasia, who was not responding to repeated sessions of Argon Plasma Coagulation (APC) and was successfully treated with trans-catheter arterial embolisation of gastro-duodenal artery. Keywords: Gastric antral vascular ectasia, Bleeding, Watermelon stomach, Argon plasma coagulation, Continuous...

scholarly journals Hyperplastic gastric polyps after argon plasma coagulation treatment of gastric antral vascular ectasia (GAVE)

Endoscopy ◽  
2007 ◽  
Vol 39 (S 1) ◽  
pp. E320-E320 ◽  
Author(s):  
J. Baudet ◽  
H. Salata ◽  
M. Soler ◽  
V. Castro ◽  
D. Díaz-Bethencourt ◽  
...  
Keyword(s):  
Argon Plasma Coagulation ◽  
Argon Plasma ◽  
Gastric Antral Vascular Ectasia ◽  
Plasma Coagulation ◽  
Vascular Ectasia ◽  
Gastric Polyps

scholarly journals Long-term follow-up in patients with gastric antral vascular ectasia (GAVE) after treatment with endoscopic band ligation (EBL)

2019 ◽  
Vol 07 (12) ◽  
pp. E1624-E1629 ◽  
Author(s):  
John Eccles ◽  
Vanessa Falk ◽  
Aldo J. Montano-Loza ◽  
Sergio Zepeda-Gómez
Keyword(s):  
Clinical Response ◽  
Argon Plasma Coagulation ◽  
Deficiency Anemia ◽  
Gastric Antral Vascular Ectasia ◽  
Band Ligation ◽  
Vascular Ectasia ◽  
Transfusion Requirements ◽  
Endoscopic Band Ligation

Abstract Background and study aims Gastric antral vascular ectasia (GAVE) is a capillary-type vascular malformation of the gastric antrum, usually diagnosed endoscopically in patients presenting with iron deficiency anemia or gastrointestinal bleeding. While there is established evidence for treatment with thermal modalities, such as argon plasma coagulation (APC) therapy, more recent studies have shown endoscopic band ligation (EBL) to be safe and effective in achieving remission. Our study aimed to evaluate long-term outcomes of patients with GAVE who underwent EBL at our institution. Patients and methods We retrospectively reviewed data from 33 patients with GAVE who underwent esophagogastroduodenoscopy and EBL between September 2012 and July 2017 within our institution, looking primarily at clinical response, recurrence, and blood transfusion requirements. Results Clinical response was achieved in 27 patients (81.8%). Among responders, recurrence-free survival decreased with time from 88 % at 1 year to 44 % at 2 years. Thirteen patients (48.1 %) had recurrence of GAVE at a mean time of 18.2 months (range 4.7 – 51.8). The only predictor of recurrence was greater number of pre-procedure blood transfusions. Conclusion This is the first study to evaluate long-term response and recurrence in patients with GAVE after treatment with EBL and predictors of clinical response after initial endoscopic therapy have been identified. While we were able to demonstrate excellent remission achievement rates in our GAVE patients who had undergone EBL, close clinical follow-up is clearly required as almost 50 % will have recurrence at around 18 months.

Sa1485 Transfusion Requirement Before Argon Plasma Coagulation for Gastric Antral Vascular Ectasia Might Be Associated With Relapse Rate

2014 ◽  
Vol 79 (5) ◽  
pp. AB230
Author(s):  
Manuel A. Mahler ◽  
María L. Gonzalez ◽  
Marina Cariello ◽  
Natalia Causada Calo ◽  
Maria L. Martinez Posadas ◽  
...  
Keyword(s):  
Relapse Rate ◽  
Transfusion Requirement ◽  
Argon Plasma Coagulation ◽  
Argon Plasma ◽  
Gastric Antral Vascular Ectasia ◽  
Plasma Coagulation ◽  
Vascular Ectasia
Sign in / Sign up

Export Citation Format

Share Document